当前位置: 首页 > 期刊 > 《中国医学创新》 > 2019年第18期
编号:13420949
小儿先天性心脏病介入诊治并发症的防治(5)
http://www.100md.com 2019年6月25日 《中国医学创新》 2019年第18期
     [25]宋铁鹰,孟香果,朱宇翔,等.小儿先天性心脏病介入治疗术中并发症与麻醉安全性的相关分析[J].河北医药,2008,30(2):146-148.

    [26] Liu X Y,Wong V,Leung M.Neurologic complications due to catheterization[J].Pediatr Neurol,2001,24(4):270-275.

    [27] Rushani D,Kaufman J S,Ionescu-Ittu R,et al.Infective endocarditis in children with congenital heart disease:cumulative incidence and predictors[J].Circulation,2013,128(13):1412-1419.

    [28] Sun L C,Lai C C,Wang C Y,et al.Risk factors for infective endocarditis in children with congenital heart diseases-A nationwide population-based case control study[J].Int J Cardiol,2017,248:126-130.

    [29] Saint-Andre C,Iriart X,Ntsinjana H,et al.Residual shunt after ductus arteriosus occluder implantation complicated by late endocarditis[J].Circulation,2012,125(6):840-842.

    [30] Mottin B,Baruteau A,Boudjemline Y,et al.Transcatheter closure of coronary artery fistulas in infants and children:A French multicenter study[J].Catheter Cardiovasc Interv,2016,87(3):411-418.

    [31]李一凡,李渝芬,謝兆丰,等.经导管AMPLATZERⅡ代血管塞介入治疗儿童先天性冠状动脉瘘[J].中华儿科杂志,2016,54(6):451-455.

    [32]张晴.冠状动脉瘘经导管封堵术后的临床随访研究[D].重庆:第三军医大学,2013.

    [33]戴启明,马根山,冯毅,等.先天性冠状动脉瘘临床分析[J].江苏医药,2008,10(34):987-988.

    [34] Ravndal M E A,Christensen A H,Dohlen G,et al.Paediatric cardiac catheterisation in Norway:rates and types of complications in new terms[J].Cardiol Young,2017,27(7):1329-1335.

    [35] Huang Y C,Chang J S,Lai Y C,et al.Importance of prevention and early intervention of adverse events in pediatric cardiac catheterization:a review of three years of experience[J].Pediatr Neonatol,2009,50(6):280-286., http://www.100md.com(郑然 吴容展)
上一页1 2 3 4 5